Pharma Latch is technically validated and currently moving towards a number of pre-clinical studies. We are actively seeking collaborations with research groups and companies who are looking to improve the effectiveness of their vaccines. We are interested in working with both existing and next generation vaccines.
With both hollow and coated devices we can work with both liquid and dry form technologies. We are open to working in application areas from immunotherapies to infectious diseases. We look forward to hearing from you!
COVID 19 Partnerships
Pharma Latch offers a myriad of advantages for COVID 19 vaccine delivery. These include:
- Highly user centric facilitating self-administration
- Facilitates global, remote reach
- Compatible with any SARS-CoV-2 Antigen, mRNA, DNA etc.
- Intradermal delivery providing enhanced immune response
- Stable coating methodology removing cold chain and logistics requirements
- Low cost of goods and highly scalable manufacturing